Robitussin Cough Medicine with DXM
Allegations: Falsely marketing medicine as “Non-Drowsy” when the active ingredient causes drowsiness
Maximum Strength Robitussin Cough+Chest Congestion DM
In September 2017, a class-action lawsuit was filed against Pfizer for allegedly misleadingly marketing Maximum Strength Robitussin Cough+Chest Congestion DM to make consumers believe that the maximum strength product contains more of the active ingredients than the regular strength product when, according to the plaintiffs, the two products contain the same amount of one of the active ingredients (expectorant) and the regular strength products contains more of the other active ingredient (cough suppressant). (Haj et al v. Pfizer Inc., Case No. 17-cv-6730, N.D. Ill.)
For more information about other class-action lawsuits regarding cough medicines and TINA.org’s coverage of the products, click here.
Class-Action Tracker
ChapStick Products
Allegations: False natural claims
Robitussin Non-Drowsy Claims
Allegations: Falsely marketing products as non-drowsy when an ingredient in them causes drowsiness
Maximum Strength Robitussin Cough+Chest Congestion DM
Allegations: Deceptively marketing products as “Maximum Strength” when the dosage of the active ingredients is less than or the same as the regular strength products
ChapStick Natural Claims
In December 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare Holdings and Pfizer for allegedly falsely advertising ChapStick products as natural when, according to plaintiffs, the products contain…
Total Hydration ChapStick
December 2018: This case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. September 2016: A class-action…
The Packaging of Advil®
In October 2016, a federal court dismissed a false advertising class-action lawsuit filed against Pfizer in 2015. The complaint had alleged that the company misleadingly uses You know when you…
Centrum Multi-Vitamins
March 2016: A federal judge denied plaintiff’s request for permission to file a second amended complaint finding that the amended complaint would not survive a motion to dismiss and, as…
The Latest
CATrends: OTC Cold and Flu Medicines Falsely Marketed as ‘Non-Drowsy’
Several products marketed as ‘non-drowsy’ contain an ingredient that causes drowsiness, lawsuits claim.
Election Tally: The Misleading Ads on Tonight’s Broadcasts
TINA.org’s election coverage focuses on the questionable ads running in between the news broadcasts.
The Lowdown on Low T
Is Big Pharma marketing a drug to help aging men with low sex drives or really selling a made-up disease?
Wyeth Agrees to $490 Million Payout for Unlawful Marketing
Justice Department says company put profits over safety.
Pfizer Prescribed a Truth Pill
Pfizer overstated the benefits and efficiency of a popular antibiotic in a direct-to-consumer advertising campaign.